Insider Selling: Omada Health (NASDAQ:OMDA) President Sells 4,589 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $17.24, for a total value of $79,114.36. Following the transaction, the president directly owned 316,238 shares in the company, valued at $5,451,943.12. The trade was a 1.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The stock was sold at an average price of $12.71, for a total value of $35,956.59.

Omada Health Price Performance

Shares of NASDAQ:OMDA traded down $0.24 during trading on Tuesday, reaching $17.09. 729,778 shares of the stock were exchanged, compared to its average volume of 1,213,043. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The stock has a fifty day moving average of $15.45 and a two-hundred day moving average of $14.80. The firm has a market cap of $1.02 billion and a price-to-earnings ratio of -63.30.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. Sell-side analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On Omada Health

Several institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE grew its holdings in Omada Health by 51.5% during the first quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock worth $2,025,000 after buying an additional 54,792 shares in the last quarter. Stoic Point Capital Management LLC bought a new stake in Omada Health during the first quarter worth $1,830,000. Quantinno Capital Management LP grew its holdings in Omada Health by 464.1% during the first quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock worth $738,000 after buying an additional 48,313 shares in the last quarter. Entropy Technologies LP bought a new stake in Omada Health during the first quarter worth $194,000. Finally, Renaissance Technologies LLC grew its holdings in Omada Health by 173.9% during the first quarter. Renaissance Technologies LLC now owns 391,069 shares of the company’s stock worth $4,916,000 after buying an additional 248,269 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on OMDA shares. Evercore reaffirmed an “outperform” rating and set a $20.00 target price on shares of Omada Health in a research report on Friday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Canaccord Genuity Group set a $24.00 target price on Omada Health in a research report on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Finally, Morgan Stanley decreased their price target on Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Friday, March 6th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.